Search - tctmd.com

Displaying 21 - 40 of 69

Sort: Relevancy | Date

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

There Are Reasons to Be Cautious – Look Beyond the Anatomy!

Presenter: David Cohen

October 23, 2023

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

Presentation TCT 2022

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Presenter: David Cohen

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TVT 2022

Novel Digital Approaches to Aortic Valve Disease Screening: Introduction to the PREVUE VALVE Study

Presenter: David J. Cohen

June 09, 2022

Presentation TVT 2022

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Presenter: David Cohen

June 08, 2022

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

News Opinion Conversations in Cardiology

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

October 12, 2021

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

Todd Neale

July 26, 2021

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Opinion Conversations in Cardiology

Conversations in Cardiology: Where to Build a Hybrid Lab

December 28, 2020

Advertisement

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

There Are Reasons to Be Cautious – Look Beyond the Anatomy!

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Novel Digital Approaches to Aortic Valve Disease Screening: Introduction to the PREVUE VALVE Study

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Conversations in Cardiology: Do You Use Antibiotics in the Cath Lab?

3M TAVR: Minimalist TAVI Pathway Saves Money

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Conversations in Cardiology: Where to Build a Hybrid Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content